Boston, MA -- (SBWIRE) -- 11/15/2016 -- Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.

Technavio's analysts forecast the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global gout therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of gout and the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs.

Get More Details on this Report and a Full Table of Contents at Global Gout Therapeutics Market 2016-2020

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Gout Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AstraZeneca
-Horizon Pharma
-Takeda Pharmaceuticals

Other prominent vendors

-Ablynx
-Alder Biopharmaceuticals
-Antares Pharma
-Astellas Pharma
-Boehringer Ingelheim
-Can-Fite BioPharma
-Celgene
-Celltrion
-ChemoCentryx
-CymaBay Therapeutics
-Eisai
-Eli Lilly
-Gilead Sciences
-GlaxoSmithKline
-Incyte
-Ironwood Pharmaceuticals
-JW Pharmaceutical
-KaloBios Pharmaceuticals
-Lexicon Pharmaceuticals
-LG Life Sciences
-Merck
-Morphotek
-Novartis
-Novo Nordisk
-Regeneron Pharmaceuticals
-Sandoz
-Sanofi
-Santarus
-Selecta Biosciences
-Teijin Pharma
-UCB
-Vertex Pharmaceuticals.

Market driver

-Introduction of novel urate-lowering agents
-For a full, detailed list, view our report

Market challenge

-Low physician and patient awareness
-For a full, detailed list, view our report

Market trend

-Focus on regenerative medicines
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: AstraZeneca, Horizon Pharma, Takeda Pharmaceuticals, Ablynx, Alder Biopharmaceuticals, Antares Pharma, Astellas Pharma, Boehringer Ingelheim, Can-Fite BioPharma, Celgene, Celltrion, ChemoCentryx, CymaBay Therapeutics, Eisai, Eli Lilly, Gilead Sciences, GlaxoSmithKline, Incyte, Ironwood Pharmaceuticals, JW Pharmaceutical, KaloBios Pharmaceuticals, Lexicon Pharmaceuticals, LG Life Sciences, Merck, Morphotek, Novartis, Novo Nordisk, Regeneron Pharmaceuticals, Sandoz, Sanofi, Santarus, Selecta Biosciences, Teijin Pharma, UCB, Vertex Pharmaceuticals

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
-Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market
-Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics
-Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth
-Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics